|
|
 |
 |
 |
|
Speakers
Keynote
The Versatile Macrophage: Receptors and Inflammation
Siamon Gordon, M.D., Ph.D.
Emeritus
Professor of Cellular Pathology, University of Oxford
Visiting Scientist at the NIH

Symposium Titles & Co-Chairs
-
Tissue Crosstalk in Inflammation and Metabolism:
Adipokines and Myokines
Co-chairs: Steven Simpson, Ph.D.
(GSK) & Ken Walsh,
Ph.D., (Boston Univ)
Speaker 1: Gokhan Hotamisligil, M.D., Ph.D. (Harvard)
Reciprocity of Metabolism and Inflammation
Speaker 2: Ken
Walsh, Ph.D. (Boston Univ)
Adipokines, Myokines and Metabolic Disease
Speaker 3: Bente Pederson, M.D. (Univ of Copenhagen)
Skeletal Muscle as an Endocrine
Organ: The Rold of Myokines in Muscle-Fat Cross-Talk
Speaker 4: Jennifer
Lachey, Ph.D. (Acceleron Pharma)
Treatment with a Soluble Activin Receptor
Type IIB Attenuates Diet-Induced Obesity in High-Fat Diet-Fed Mice
-
ADVANCES
in Translational Medicine as it Applies to
Inflammatory Diseases
Co-Chairs: Lisa Schopf, Ph.D.
(Verdante Pharmaceuticals) & Bill Selig, Ph.D.
Speaker 1: Jeff Voss, Ph.D. (Abbott)
Translational Analysis of Autoimmune Disease mRNA Expression Data
Speaker 2: Bitao Liang, Ph.D.
(Celgene)
Mesenchymal Stromal (MSC)-Like Cells in Autoimmune
and Anti-Inflammatory Applications
Speaker 3: Christine Ward, Ph.D. (MedImmune)
Translational Strategies for Respiratory Drug Development
Speaker 4: William Westlin, Ph.D. (Avila Therapeutics)
Translational Pharmacology of
AVL-292, A Potent and Selective Inhibitor of Bruton’s Tyrosine
Kinase
-
Molecular and Cellular Crosstalk in
Inflammation Network: the Role of Macrophages and Dendritic
Cells
Co-Chairs: Annalisa D'Andrea, Ph.D. (SRI Int Biosciences) &
Liwu Li, Ph.D. (Virginia Tech)
Speaker 1: Giorgio Trinchieri, M.D. (NCI)
Innate Resistance, Inflammation
and Cancer
Speaker 2: Carla Rothlin, Ph.D. (Yale)
TAMing Inflammation In Vivo
Speaker 3: Kate Fitzgerald, Ph.D. (U Mass)
Cytosolic DNA Sensors and Innate Immunity
Speaker 4: Stefanie Vogel, Ph.D. (U Maryland)
Role of Alternatively Activated Macrophages in the
Resolution of RSV-Induced Disease
-
Lupus: From Basic Mechanisms to the Clinic
Co-Chairs: Laura Carter, Ph.D. (Array
BioPharma) & Joan Merrill, M.D. (Oklahoma Medical Res Found)
Speaker 1: Gregg Silverman, M.D. (UCSD)
Roles of B Cells in Lupus Pathogenesis
Speaker 2: Franck Barrat, Ph.D. (Dynavax)
Plasmacytoid Dendritic Cell Activation Hampers
Glucocorticoids Anti-Inflammatory Activity in SLE
Speaker 3: Joan Merrill, M.D. (Oklahoma Medical Res Found)
Overview of Lupus Clinical Development Programs
-
Novel Therapeutics
Co-Chairs: Bruce Tomczuk, Ph.D. (Arginetix) & Spencer Danto,
M.D., Ph.D. (Pfizer)
Speaker 1: Alison Humbles, Ph.D. (MedImmune)
MEDI-563, A Humanized Anti-IL-5 Receptor Alpha MAb with Enhanced
Antibody-Dependent Cell-Mediated Function for the Treatment of Asthma
Speaker 2: Marina Roell, Ph.D. (XOMA)
Regulating IL-1 Activity with XOMA 052, A Therapeutic Antibody with a Novel
Mechansim of Action
Speaker 3: David Martin, M.D. (Amgen)
Targeting the IL-17 Axis: From Bench to Bedside
Mini Symposia
-
Innate Immune Responses
Co-Chairs: Laurent Audoly, Ph.D. (Merck) & Bassil Dahiyat, Ph.D.
(Xencor)
Invited Speaker: Basil Dahiyat, Ph.D. (Xencor)
Tuning Effector Cell Responses to MAb Therapies via Fc
Engineering: Clinical and Pre-Clinical Experiences
Plus 4 oral presentations selected from submitted abstracts
-
Adaptive Immune Responses
Co-Chairs: Robert Benschop, Ph.D. (Lilly) & Barb Vilen, Ph.D. (UNC)
Invited Speaker: Barb Vilen, Ph.D. (UNC)
Regulating Immunoglobulin Secretion During Adaptive Immune Responses
Plus 4 oral presentations selected from submitted abstracts

^
TOP of PAGE
|
 |
 |
|